PolyTherics Granted Further Patents for TheraPEG™ and GlycoPol™
6/18/2012 11:16:33 AM
More...
|
Pro Bono Bio and PolyTherics Progress and Expand Their Relationship for the Development of Improved Blood Factors
5/29/2012 10:13:14 AM
More...
|
New Board Members Join PolyTherics
5/15/2012 11:47:18 AM
More...
|
PolyTherics and Spirogen Ltd. Announce a Research Collaboration to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
4/2/2012 10:25:04 AM
More...
|
PolyTherics Announces a Research Collaboration With Spirogen Ltd. to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
4/2/2012 9:35:55 AM
More...
|
PolyTherics Acquires Warwick Effect Polymers and Expands Technology Portfolio to Enable the Development of Better Biopharmaceuticals
1/20/2012 6:42:19 AM
More...
|
Nuron Biotech Exercises Option for a Licence to PolyTherics' TheraPEG™ Technology to Develop a Long-Acting Human Interferon beta-1b
12/13/2011 9:28:11 AM
More...
|
PolyTherics Raises Further Funding to Enable Commercialisation of Technologies for Development of Better Biopharmaceuticals
9/7/2011 11:05:57 AM
More...
|
Keith Powell Hands Over to John Burt to Lead PolyTherics as New CEO
5/16/2011 10:03:57 AM
More...
|
PolyTherics and Critical Pharmaceuticals Limited Enter Drug Development Collaboration with Funding From the Technology Strategy Board
4/5/2011 8:53:23 AM
More...
|
|